| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2022-01-18 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $4.67B | $3.50B | $2.39B | $2.00B | – | $4.98B |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $4.09B | $3.58B | $2.36B | $1.94B | – | $916.57M |
| R&D | – | – | – | – | – | – |
| SG&A | $702.17M | $583.73M | $482.57M | $368.92M | – | $278.59M |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | $102.30M | $77.10M | $31.80M | $19.00M | – | $14.30M |
| Tax Expense | $66.99M | $52.09M | $60.27M | $32.48M | – | $9.04M |
| Net Income | $184.59M | $23.48M | $80.09M | -$56.23M | $6.22M | $0.00 |
| EPS (basic) | 0.8900 | 0.0000 | 0.8900 | 1.1000 | – | 0.0000 |
| EPS (diluted) | 0.4500 | -0.4200 | -0.0400 | -0.1900 | – | 0.0000 |
| Shares (diluted) | $374.13M | $364.73M | $317.94M | $308.91M | – | $0.00 |